EXT2 antibody (AA 180-267)
Quick Overview for EXT2 antibody (AA 180-267) (ABIN7152309)
Target
See all EXT2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 180-267
-
Cross-Reactivity
- Human
-
Purification
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Exostosin-2 protein (180-267AA)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Recommended dilution: IHC:1:20-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- EXT2 (Exostosin 2 (EXT2))
-
Alternative Name
- EXT2
-
Background
-
Background: Glycosyltransferase required for the biosynthesis of heparan-sulfate. The EXT1/EXT2 complex possesses substantially higher glycosyltransferase activity than EXT1 or EXT2 alone. Appears to be a tumor suppressor. Required for the exosomal release of SDCBP, CD63 and syndecan (PubMed:22660413).
Aliases: Exostoses (multiple) 2 antibody, Exostosin 2 antibody, Exostosin-2 antibody, EXT2 antibody, EXT2_HUMAN antibody, Glucuronosyl N acetylglucosaminyl proteoglycan 4 alpha N acetylglucosaminyltransferase antibody, Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase antibody, Multiple exostoses protein 2 antibody, N acetylglucosaminyl proteoglycan 4 beta glucuronosyltransferase antibody, Putative tumor suppressor protein EXT2 antibody, SOTV antibody
-
UniProt
- Q93063
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-